AzTrials
AzTrials

Parkinson's DiseaseNCT02419768

Effects of Exercise on Long-Range Autocorrelations in Parkinson's Disease

A study testing Physical Exercise in people with Parkinson's Disease, run by Cliniques universitaires Saint-Luc- Université Catholique de Louvain at 1 site in Belgium.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Parkinson's disease (PD) is one of the most common neurodegenerative disorders. The parkinsonian gait is characterized by reducted stride length and gait speed, postural disorders (with a high risk of falling) and a modification of stride duration variability. Read more about this study

Who is it for?
Any age
Conditions the study is for
Parkinson's Disease
What is being tested?
Physical Exercise
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteBelgium
Study dates
Jun 2014to May 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Diagnosis idiopathic Parkinson according to the Brain Bank criteria of the United Kingdom Parkinson's Disease Society
  • Disease severity according to modified Hoehn \& Yahr stages I to IV
  • Absence of dementia Minimal Mini Mental State Examination score of 24 or higher
  • Stable drug usage in the last 4 weeks
  • Adequate vision and hearing, achieved using corrective lenses and/or hearing aid if required

Who cannot join

  • Severe co-morbidity, other neurological problems, acute medical problems (e.g. MI, diabetes) and joint problems affecting mobility
  • Unpredictable "Off"-periods (score >2, MDS-UPDRS item 4.5)

Trial locations and contacts

1 site in 1 country.

Thierry Lejeune, Professor contact

+32 2 764 16 48

thierry.lejeune@uclouvain.be

Belgium1 site, 1 recruiting
  • Université catholique de Louvain - Cliniques universitaires Saint-Luc

    Woluwé-Saint-Lambert, Brussels Capital, 1200

    Thierry Lejeune, Professor, +32 2 764 16 48, thierry.lejeune@uclouvain.be

    Recruiting

Other trials in Belgium

About this study

Official title: Locomotion of Parkinsonian Patient: Are There Relations Between the Long Range Autocorrelations and the Neurological Impairments, Walking Abilities and the Practice of Physical Exercise?

Parkinson's disease (PD) is one of the most common neurodegenerative disorders. The parkinsonian gait is characterized by reducted stride length and gait speed, postural disorders (with a high risk of falling) and a modification of stride duration variability. This variability can be assessed by its magnitude (SD and CV) and its temporal organization (long-range autocorrelations). Healthy human gait presents with an interdependency between consecutive cycles that can span over hundreds of strides (long-range autocorrelations). Numerous observations plead for a relation between long-range autocorrelations and functional abilities of the system. Complementary to drugs, rehabilitation becomes an important way to treat PD.

The aim of our study is to assess by a controlled, randomized, single blinded clinical study, the effect of physical exercise on stride duration variability, neurological impairments and walking abilities of parkinsonian patients.

Physical exercise program will include 30 sessions spread over 15 weeks following the guidelines. Long-range correlations analysis, including the study of Hurst and α exponents, will be performed on a minimum of 512 consecutive cycles. Finally, the functional assessment of the parkinsonian patient will be done according to International Classification of Functioning Disability and Health (ICF).

Read the detailed description

BACKGROUND

One of the most common features of human movement is its variability across multiple repetition of the same rhythmic task (1). In humans, many periodic signals, such as gait, heartbeat, respiratory and neuronal activities are characterized by their temporal complexity, fluctuating in a complex manner over time. Although fluctuations between cycles could appear to vary randomly, without apparent correlations between cycles, healthy systems possess the memory of preceding values of the series displaying a complex temporal structure.

In order to assess variability in physiological time series, several mathematical methods can be used. On one hand, classical mathematical methods, usually applied on shorter time series (tens of data points), quantify the fluctuation magnitude in a set of values independently of their order in the distribution, by computing the standard deviation (SD) and the coefficient of variation (CV). On the other hand, more complex mathematical methods, applied on longer time series (≥512 cycles), can be used to assess the fluctuation dynamics over time (3). These latter methods have demonstrated that variability of numerous physiological signals (cardiac and respiratory rhythm or locomotor activities e.g.) exhibit long-range autocorrelations, whereby the statistical inter-dependency between cycles spans of a very large number of cycles (14).

This temporal organization of variability is thus an intrinsic property within numerous biological systems. Moreover, it could provide insight into the neurophysiological organization and into the regulation of these systems (32). Recent studies claimed that these fluctuations, included in an optimal range, would represent the underlying physiologic capability to make flexible adaptations to everyday stresses placed on the human body (32). Therefore, the presence of such temporal dynamics is thought to be a critical marker of health and their breakdown as an index of pathological condition (18, 25, 32). In human heart rate for instance, deviations from an optimum of variability in either the direction of randomness (atrial fibrillation e.g.) or the over-regularity (congestive heart failure e.g.) indicate the loss of the adaptive capabilities of the system (9, 32).

Alongside, some central nervous system diseases influence the variability, especially, of gait. Indeed, neurodegenerative disorders such as Parkinson and Huntington diseases are characterized, among others, by a modification of walking variability (observed by a breakdown of long-range autocorrelations) and a high risk of falling. Although the origin of long-range autocorrelation remains unknown, their breakdown in such diseases suggests a central control mechanism (8, 11, 13, 16, 17, 36).

RESEARCH PROJECT

Affecting about 1% of the population over the age of 60, Parkinson's disease (PD) is one of the most common neurodegenerative disorders. PD is progressive in nature, and so patients face increased difficulties with activities of daily living and various aspects of mobility such as gait, transfers, balance, and posture. Ultimately, this leads to decreased independence, inactivity, and social isolation, resulting in reduced quality of life. Consequently, the improvement of locomotion is one of the most important aims of the management of PD.

The management of PD has traditionally centered on drug therapy, with levodopa viewed as the "gold standard" treatment. However, even with optimal medical management, parkinsonian patients experience deterioration in body function, daily activities and participation. For this reason, support has been increasing for the inclusion of rehabilitation therapies as an adjuvant to pharmacological and neurosurgical treatment. Indeed, regular physical activity slows down the progression and decrease the fall risk. Moreover, exercise has demonstrated its effectiveness for both preservation of functional abilities and prevention of complications (cardiovascular, osteoporosis,…).

Until now, few studies have included the analysis of variability in the functional assessment of patients presenting a neurological disease, such as PD. Yet, walking disorders and falls represent not only an important cost for the society but also a sizeable individual risk of morbi/mortality. An appropriate rehabilitation program should allow for reduction at once the risks and costs resulting from these disorders. The investigator hypothesize that the analysis of walking variability could be useful as clinical tool in the assessment of fall risk and as assessment tool of the therapeutic effectiveness (medication and/or physical exercise) in PD. Therefore, the aims of this study are (1) to assess the influence of physical exercise on human walking variability and (2) to study its potential correlations with walking abilities and neurological impairments of parkinsonian patients.

Patients

The investigators will recruit 50 patients with idiopathic Parkinson's disease from the department of Neurology of Cliniques universitaires Saint-Luc (Brussels, Belgium) The study is approved by the ethics committee. All patients will give informed written consent to the study. Eligibility criteria are: diagnosis idiopathic Parkinson (according to the Brain Bank criteria of the United Kingdom Parkinson's Disease Society), disease severity (according to modified Hoehn \& Yahr stages I to IV), absence of dementia (Minimal Mini Mental State Examination score of 24 or higher), stable drug usage in the last 4 weeks and adequate vision and hearing, achieved using corrective lenses and/or hearing aid if required. Patients will be excluded if they have severe co-morbidity, other neurological problems, acute medical problems (e.g. MI, diabetes) and joint problems affecting mobility, and unpredictable "Off"-periods (score >2, MDS-UPDRS item 4.5).

Procedure

The present study is a controlled, randomized, single blinded clinical study with a crossover design. The control group will not change its usual physical activity whereas the intervention group will benefit from the physical exercise program. This latter will include 30 sessions of circuit-group training of 60 min (twice a week) spread over 15 weeks. Then, the two groups will be crossed. According to the recent guidelines, the program will include a specific work on balance, posture, gait, fitness, dual tasks and stretching. All sessions will be performed at an adequate intensity (i.e. 60-80% of predicted maximal heart rate). At least 512 cycles will be recorded (at a high sampling rate (512 Hz)) on a treadmill at a self-selected comfortable speed using a unidimensional accelerometer taped on the right lateral malleolus.

Functional assessment based on the 3 domains of the International Classification of Functioning, Disability and Health (ICF)

Patients will be assessed before intervention (T0) and at 15 (T1), 30 (T2), 45 (T3) and 60 weeks (T4) among the 3 ICF domains:

Impairments will assessed by MDS-UPDRS, an instrumented gait analysis (kinematic, kinetic, electromyographic and energetic) (18), the 6 minute walk distance, the 10 meter walk test, the ABC-Scale and the BESTest (including the Functional Reach Test, the Push \& Release and the Get Up \& Go test).

Activities, participation and quality of life will be evaluated the Impact on Participation and Autonomy Questionnaire (IPAQ) and a fall diary.

Walking variability analysis

Revolution time variability will be appreciated by classical and complex mathematical methods. Classical mathematical methods (standard deviation, coefficient of variation) allow for evaluating the fluctuation magnitude, while complex mathematical methods (long-range autocorrelations) assess the dynamics of fluctuations over time (3).

The presence of long-range autocorrelations will be evaluated using the integrated approach proposed by Rangarajan and Ding and validated by Crevecoeur et al. in the context of physiological time series. These methods are described in greater details elsewhere. Briefly, the Hurst exponent (H) will be calculated using the rescaled range analysis and the α exponent will be evaluated using the power spectral density of the time series. For each time series, both methods will be applied to sequences of 512 consecutive gait strides.

In theory, the exponents H and α are asymptotically related by the relation H. Hence, the integrated approach consists of separately computing H and α, and verifying that these two parameters are consistent through the equation d=H-(1+α)/2=0. A value of d ≤ 0.10 is considered acceptable since the asymptotic parameters are evaluated on finite time series.

In summary, the following three conditions must be satisfied to conclude for the presence of long-range autocorrelations :

H > 0.5; α is significantly different from 0 and lower than 1; and d ≤ 0.10

When inconsistencies appear between H and α, the investigators will use the randomly shuffled surrogate data test to reject the null hypothesis that the series under investigation has no temporal structure (i.e. uncorrelated random process).

PERSPECTIVES

By studying the influence of physical exercise on human walking variability and its potential correlations with walking abilities and neurological impairments of parkinsonian patients, the investigators hope to demonstrate that the analysis of walking variability could be use as a clinical tool in the assessment of fall risk and as an assessment tool of the therapeutic effectiveness (medication and/or physical exercise) in PD.

Being tested
Physical Exercise
Keywords
Long-range autocorrelations, Variability, Physical Exercise, Parkinson's Disease, ICF
Medical subject headings
Parkinson Disease, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Physical ExerciseOther

    The physical exercise program will include 30 sessions of 60 minutes (twice a week). According to the recent guidelines, the program will include a specific work on balance, posture, gait, fitness, dual tasks and stretching.

Study groups in NCT02419768
Study groupRoleWhat they receive
Physical ExerciseExperimentalAll patients will receive a circuit-group training including a specific work of balance, posture, gait, fitness, dual tasks and stretching.
Receives: Other: Physical Exercise
ControlNo interventionAll patients will not change their physical activities

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Balance Evaluation Systems Test (BESTest)

    Measured: Change from baseline in balance measures at an expected average of 15 (T1), 30 (T2), 45 (T3) and 60 weeks (T4)

Secondary outcomes (7)
  1. Movement Disorder Society-Unified Parkinson Disease Rating Scale (MDS-UPDRS)

    Measured: Change from baseline in MDS-UPDRS at an expected average of 15 (T1), 30 (T2), 45 (T3) and 60 weeks (T4)

  2. Six Minute Walk Distance (6-MWD)

    Measured: Change from baseline in exercise tolerance at an expected average of 15 (T1), 30 (T2), 45 (T3) and 60 weeks (T4)

  3. 10 Meter Walk Test (10-MWT)

    Measured: Change from baseline in walking speed, step lenght and cadence at an expected average of 15 (T1), 30 (T2), 45 (T3) and 60 weeks (T4)

  4. Long-range autocorrelations

    Measured: Change from baseline in long-range autocorrelations at an expected average of 15 (T1), 30 (T2), 45 (T3) and 60 weeks (T4)

  5. Instrumented gait analysis

    Measured: Change from baseline in gait parameters (kinematic, kinetic, electromyographic and energetic) at an expected average of 15 (T1), 30 (T2), 45 (T3) and 60 weeks (T4)

  6. Impact on Participation and Autonomy Questionnaire (IPAQ)

    Measured: Change from baseline in participation and quality of life at an expected average of 15 (T1), 30 (T2), 45 (T3) and 60 weeks (T4)

  7. Activities-specific Balance Confidence Scale (ABC-Scale)

    Measured: Change from baseline in subjective balance measures (fear of falling) at an expected average of 15 (T1), 30 (T2), 45 (T3) and 60 weeks (T4)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Apr 2015 (estimated)
  2. Study startJun 2014
  3. Primary completionMay 2016 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Allocation
Randomised
Intervention model
Crossover
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02419768
Sponsor's protocol ID
IONS - Warlop - 01
Status last verified
Jan 2016
First submitted
14 Apr 2015
Last updated
28 Jan 2016
Results posted
No
Data monitoring committee
Yes

Publications

  • Stergiou N, Decker LM. Human movement variability, nonlinear dynamics, and pathology: is there a connection? Hum Mov Sci. 2011 Oct;30(5):869-88. doi: 10.1016/j.humov.2011.06.002. Epub 2011 Jul 29.

    PubMed 21802756
  • Hausdorff JM. Gait dynamics, fractals and falls: finding meaning in the stride-to-stride fluctuations of human walking. Hum Mov Sci. 2007 Aug;26(4):555-89. doi: 10.1016/j.humov.2007.05.003. Epub 2007 Jul 5.

    PubMed 17618701
  • Hausdorff JM, Cudkowicz ME, Firtion R, Wei JY, Goldberger AL; New Collective Author. Gait variability and basal ganglia disorders: stride-to-stride variations of gait cycle timing in Parkinson's disease and Huntington's disease. Mov Disord. 1998 May;13(3):428-37. doi: 10.1002/mds.870130310.

    PubMed 9613733
  • Peng CK, Havlin S, Stanley HE, Goldberger AL; New Collective Author. Quantification of scaling exponents and crossover phenomena in nonstationary heartbeat time series. Chaos. 1995;5(1):82-7. doi: 10.1063/1.166141.

    PubMed 11538314
  • Goldberger AL, Amaral LA, Hausdorff JM, Ivanov PCh, Peng CK, Stanley HE. Fractal dynamics in physiology: alterations with disease and aging. Proc Natl Acad Sci U S A. 2002 Feb 19;99 Suppl 1(Suppl 1):2466-72. doi: 10.1073/pnas.012579499.

    PubMed 11875196
  • Bollens B, Crevecoeur F, Nguyen V, Detrembleur C, Lejeune T. Does human gait exhibit comparable and reproducible long-range autocorrelations on level ground and on treadmill? Gait Posture. 2010 Jul;32(3):369-73. doi: 10.1016/j.gaitpost.2010.06.011. Epub 2010 Jul 15.

    PubMed 20637627
  • Bollens B, Crevecoeur F, Detrembleur C, Guillery E, Lejeune T. Effects of age and walking speed on long-range autocorrelations and fluctuation magnitude of stride duration. Neuroscience. 2012 May 17;210:234-42. doi: 10.1016/j.neuroscience.2012.02.039. Epub 2012 Mar 5.

    PubMed 22421102
  • Crevecoeur F, Bollens B, Detrembleur C, Lejeune TM. Towards a "gold-standard" approach to address the presence of long-range auto-correlation in physiological time series. J Neurosci Methods. 2010 Sep 30;192(1):163-72. doi: 10.1016/j.jneumeth.2010.07.017. Epub 2010 Jul 21.

    PubMed 20654647
  • Diniz A, Wijnants ML, Torre K, Barreiros J, Crato N, Bosman AM, Hasselman F, Cox RF, Van Orden GC, Delignieres D. Contemporary theories of 1/f noise in motor control. Hum Mov Sci. 2011 Oct;30(5):889-905. doi: 10.1016/j.humov.2010.07.006. Epub 2010 Dec 31.

    PubMed 21196059
  • Dingwell JB, John J, Cusumano JP. Do humans optimally exploit redundancy to control step variability in walking? PLoS Comput Biol. 2010 Jul 15;6(7):e1000856. doi: 10.1371/journal.pcbi.1000856.

    PubMed 20657664
  • Gates DH, Dingwell JB. Peripheral neuropathy does not alter the fractal dynamics of stride intervals of gait. J Appl Physiol (1985). 2007 Mar;102(3):965-71. doi: 10.1152/japplphysiol.00413.2006. Epub 2006 Nov 16.

    PubMed 17110519
  • Hausdorff JM, Ashkenazy Y, Peng CK, Ivanov PC, Stanley HE, Goldberger AL. When human walking becomes random walking: fractal analysis and modeling of gait rhythm fluctuations. Physica A. 2001 Dec 15;302(1-4):138-47. doi: 10.1016/s0378-4371(01)00460-5.

    PubMed 12033228
  • Paterson K, Hill K, Lythgo N. Stride dynamics, gait variability and prospective falls risk in active community dwelling older women. Gait Posture. 2011 Feb;33(2):251-5. doi: 10.1016/j.gaitpost.2010.11.014. Epub 2010 Dec 16.

    PubMed 21167715
  • Gillespie LD, Robertson MC, Gillespie WJ, Sherrington C, Gates S, Clemson LM, Lamb SE. Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD007146. doi: 10.1002/14651858.CD007146.pub3.

    PubMed 22972103
  • Keus SH, Munneke M, Nijkrake MJ, Kwakkel G, Bloem BR. Physical therapy in Parkinson's disease: evolution and future challenges. Mov Disord. 2009 Jan 15;24(1):1-14. doi: 10.1002/mds.22141.

    PubMed 18946880

Questions about this trial

What is this clinical trial studying?

A study testing Physical Exercise in people with Parkinson's Disease, run by Cliniques universitaires Saint-Luc- Université Catholique de Louvain at 1 site in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 28 Jan 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Thierry Lejeune, Professor (+32 2 764 16 48, thierry.lejeune@uclouvain.be), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Balance Evaluation Systems Test (BESTest) (time frame: Change from baseline in balance measures at an expected average of 15 (T1), 30 (T2), 45 (T3) and 60 weeks (T4)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02419768, which also lists 24 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Jan 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in